annual current liabilities:
$49.55M-$17.86M(-26.50%)Summary
- As of today (September 18, 2025), CDTX annual total current liabilities is $49.55 million, with the most recent change of -$17.86 million (-26.50%) on December 31, 2024.
- During the last 3 years, CDTX annual current liabilities has risen by +$15.54 million (+45.67%).
- CDTX annual current liabilities is now -26.50% below its all-time high of $67.42 million, reached on December 31, 2023.
Performance
CDTX Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$32.32M-$16.49M(-33.79%)Summary
- As of today (September 18, 2025), CDTX quarterly total current liabilities is $32.32 million, with the most recent change of -$16.49 million (-33.79%) on June 30, 2025.
- Over the past year, CDTX quarterly current liabilities has dropped by -$7.33 million (-18.48%).
- CDTX quarterly current liabilities is now -52.06% below its all-time high of $67.42 million, reached on December 31, 2023.
Performance
CDTX quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
CDTX Current liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -26.5% | -18.5% |
3 y3 years | +45.7% | +2.7% |
5 y5 years | +64.1% | +2.4% |
CDTX Current liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -26.5% | +45.7% | -52.1% | +2.9% |
5 y | 5-year | -26.5% | +64.1% | -52.1% | +2.9% |
alltime | all time | -26.5% | >+9999.0% | -52.1% | +953.4% |
CDTX Current liabilities History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $32.32M(-33.8%) |
Mar 2025 | - | $48.81M(-1.5%) |
Dec 2024 | $49.55M(-26.5%) | $49.55M(+11.8%) |
Sep 2024 | - | $44.34M(+11.8%) |
Jun 2024 | - | $39.64M(-39.4%) |
Mar 2024 | - | $65.42M(-3.0%) |
Dec 2023 | $67.42M(+62.8%) | $67.42M(+89.3%) |
Sep 2023 | - | $35.62M(+13.4%) |
Jun 2023 | - | $31.42M(-11.9%) |
Mar 2023 | - | $35.66M(-13.9%) |
Dec 2022 | $41.40M(+21.7%) | $41.40M(+25.3%) |
Sep 2022 | - | $33.05M(+5.1%) |
Jun 2022 | - | $31.45M(-2.0%) |
Mar 2022 | - | $32.10M(-5.6%) |
Dec 2021 | $34.02M(-11.8%) | $34.02M(+1.6%) |
Sep 2021 | - | $33.49M(-1.2%) |
Jun 2021 | - | $33.89M(-15.2%) |
Mar 2021 | - | $39.97M(+3.6%) |
Dec 2020 | $38.56M(+27.7%) | $38.56M(+13.9%) |
Sep 2020 | - | $33.87M(+7.3%) |
Jun 2020 | - | $31.57M(+6.5%) |
Mar 2020 | - | $29.63M(-1.9%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2019 | $30.20M(+51.8%) | $30.20M(-4.4%) |
Sep 2019 | - | $31.58M(+69.7%) |
Jun 2019 | - | $18.61M(-1.5%) |
Mar 2019 | - | $18.90M(-5.0%) |
Dec 2018 | $19.89M(+64.6%) | $19.89M(+46.7%) |
Sep 2018 | - | $13.56M(-9.1%) |
Jun 2018 | - | $14.92M(+29.5%) |
Mar 2018 | - | $11.52M(-4.7%) |
Dec 2017 | $12.09M(+35.6%) | $12.09M(+40.2%) |
Sep 2017 | - | $8.62M(-19.1%) |
Jun 2017 | - | $10.66M(+54.8%) |
Mar 2017 | - | $6.89M(-22.7%) |
Dec 2016 | $8.91M(+49.1%) | $8.91M(+8.2%) |
Sep 2016 | - | $8.23M(+60.6%) |
Jun 2016 | - | $5.13M(+26.4%) |
Mar 2016 | - | $4.06M(-32.1%) |
Dec 2015 | $5.97M(+85.9%) | $5.97M(+39.7%) |
Sep 2015 | - | $4.28M(+39.3%) |
Jun 2015 | - | $3.07M(-19.5%) |
Mar 2015 | - | $3.81M(+18.5%) |
Dec 2014 | $3.21M(+2669.8%) | $3.21M |
Dec 2013 | $116.00K | - |
FAQ
- What is Cidara Therapeutics, Inc. annual total current liabilities?
- What is the all time high annual current liabilities for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. annual current liabilities year-on-year change?
- What is Cidara Therapeutics, Inc. quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. quarterly current liabilities year-on-year change?
What is Cidara Therapeutics, Inc. annual total current liabilities?
The current annual current liabilities of CDTX is $49.55M
What is the all time high annual current liabilities for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high annual total current liabilities is $67.42M
What is Cidara Therapeutics, Inc. annual current liabilities year-on-year change?
Over the past year, CDTX annual total current liabilities has changed by -$17.86M (-26.50%)
What is Cidara Therapeutics, Inc. quarterly total current liabilities?
The current quarterly current liabilities of CDTX is $32.32M
What is the all time high quarterly current liabilities for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high quarterly total current liabilities is $67.42M
What is Cidara Therapeutics, Inc. quarterly current liabilities year-on-year change?
Over the past year, CDTX quarterly total current liabilities has changed by -$7.33M (-18.48%)